BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 35079820)

  • 1. Allograft dysfunction after lung transplantation for COPA syndrome: A case report and literature review.
    Matsubayashi T; Yamamoto M; Takayama S; Otsuki Y; Yamadori I; Honda Y; Izawa K; Nishikomori R; Oto T
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):314-318. PubMed ID: 35079820
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmentation of Stimulator of Interferon Genes-Induced Type I Interferon Production in COPA Syndrome.
    Kato T; Yamamoto M; Honda Y; Orimo T; Sasaki I; Murakami K; Hemmi H; Fukuda-Ohta Y; Isono K; Takayama S; Nakamura H; Otsuki Y; Miyamoto T; Takita J; Yasumi T; Nishikomori R; Matsubayashi T; Izawa K; Kaisho T
    Arthritis Rheumatol; 2021 Nov; 73(11):2105-2115. PubMed ID: 33982886
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unprecedented COPA gene mutation in two patients in the same family: comparative clinical analysis of newly reported patients with other known COPA gene mutations.
    Patwardhan A; Spencer CH
    Pediatr Rheumatol Online J; 2019 Aug; 17(1):59. PubMed ID: 31455335
    [TBL] [Abstract][Full Text] [Related]  

  • 4. STING-Mediated Lung Inflammation and Beyond.
    Frémond ML; Crow YJ
    J Clin Immunol; 2021 Apr; 41(3):501-514. PubMed ID: 33532887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPA syndrome, 5 years after: Where are we?
    Frémond ML; Nathan N
    Joint Bone Spine; 2021 Mar; 88(2):105070. PubMed ID: 32919065
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Defect in Thymic Tolerance Causes T Cell-Mediated Autoimmunity in a Murine Model of COPA Syndrome.
    Deng Z; Law CS; Ho FO; Wang KM; Jones KD; Shin JS; Shum AK
    J Immunol; 2020 May; 204(9):2360-2373. PubMed ID: 32198142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type I interferon pathway activation in COPA syndrome.
    Volpi S; Tsui J; Mariani M; Pastorino C; Caorsi R; Sacco O; Ravelli A; Shum AK; Gattorno M; Picco P
    Clin Immunol; 2018 Feb; 187():33-36. PubMed ID: 29030294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COPA syndrome in an Icelandic family caused by a recurrent missense mutation in COPA.
    Jensson BO; Hansdottir S; Arnadottir GA; Sulem G; Kristjansson RP; Oddsson A; Benonisdottir S; Jonsson H; Helgason A; Saemundsdottir J; Magnusson OT; Masson G; Thorisson GA; Jonasdottir A; Jonasdottir A; Sigurdsson A; Jonsdottir I; Petursdottir V; Kristinsson JR; Gudbjartsson DF; Thorsteinsdottir U; Arngrimsson R; Sulem P; Gudmundsson G; Stefansson K
    BMC Med Genet; 2017 Nov; 18(1):129. PubMed ID: 29137621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. COPA syndrome caused by a novel p.Arg227Cys COPA gene variant.
    Zheng Y; Du Y; Wu Y; Li F; Gu W; Zhao C
    Mol Genet Genomic Med; 2024 Jan; 12(1):e2309. PubMed ID: 37877458
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interstitial lung disease in autoinflammatory disease in childhood: A systematic review of the literature.
    Nayir Buyuksahin H; Basaran O; Balık Z; Bilginer Y; Ozen S; Dogru D
    Pediatr Pulmonol; 2023 Feb; 58(2):367-373. PubMed ID: 36314652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-6 receptor blockade for allograft dysfunction after lung transplantation in a patient with COPA syndrome.
    Riddell P; Moshkelgosha S; Levy L; Chang N; Pal P; Halloran K; Halloran P; Parkes M; Singer LG; Keshavjee S; Martinu T; Juvet SC
    Clin Transl Immunology; 2021; 10(2):e1243. PubMed ID: 33537146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Baricitinib in therapy of COPA syndrome in a 15-year-old girl.
    Krutzke S; Rietschel C; Horneff G
    Eur J Rheumatol; 2020 Feb; 7(Suppl1):S78-S81. PubMed ID: 31449490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Longitudinal assessment of interstitial lung disease in single lung transplant recipients with scleroderma.
    Hinze AM; Lin CT; Hussien AF; Perin J; Venado A; Golden JA; Boin F; Brown RH; Wise RA; Wigley FM
    Rheumatology (Oxford); 2020 Apr; 59(4):790-798. PubMed ID: 31504916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Copa Syndrome: a Novel Autosomal Dominant Immune Dysregulatory Disease.
    Vece TJ; Watkin LB; Nicholas S; Canter D; Braun MC; Guillerman RP; Eldin KW; Bertolet G; McKinley S; de Guzman M; Forbes L; Chinn I; Orange JS
    J Clin Immunol; 2016 May; 36(4):377-387. PubMed ID: 27048656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expanding the phenotype of COPA syndrome: a kindred with typical and atypical features.
    Taveira-DaSilva AM; Markello TC; Kleiner DE; Jones AM; Groden C; Macnamara E; Yokoyama T; Gahl WA; Gochuico BR; Moss J
    J Med Genet; 2019 Nov; 56(11):778-782. PubMed ID: 30385646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of COPA syndrome.
    Kumrah R; Mathew B; Vignesh P; Singh S; Rawat A
    Appl Clin Genet; 2019; 12():11-18. PubMed ID: 30804679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COPA Syndrome from Diagnosis to Treatment: A Clinician's Guide.
    Simchoni N; Vogel TP; Shum AK
    Rheum Dis Clin North Am; 2023 Nov; 49(4):789-804. PubMed ID: 37821196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterozygous mutations in the C-terminal domain of COPA underlie a complex autoinflammatory syndrome.
    Delafontaine S; Iannuzzo A; Bigley TM; Mylemans B; Rana R; Baatsen P; Poli MC; Rymen D; Jansen K; Mekahli D; Casteels I; Cassiman C; Demaerel P; Lepelley A; Frémond ML; Schrijvers R; Bossuyt X; Vints K; Huybrechts W; Tacine R; Willekens K; Corveleyn A; Boeckx B; Baggio M; Ehlers L; Munck S; Lambrechts D; Voet A; Moens L; Bucciol G; Cooper MA; Davis CM; Delon J; Meyts I
    J Clin Invest; 2024 Jan; 134(4):. PubMed ID: 38175705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. COPA mutations impair ER-Golgi transport and cause hereditary autoimmune-mediated lung disease and arthritis.
    Watkin LB; Jessen B; Wiszniewski W; Vece TJ; Jan M; Sha Y; Thamsen M; Santos-Cortez RL; Lee K; Gambin T; Forbes LR; Law CS; Stray-Pedersen A; Cheng MH; Mace EM; Anderson MS; Liu D; Tang LF; Nicholas SK; Nahmod K; Makedonas G; Canter DL; Kwok PY; Hicks J; Jones KD; Penney S; Jhangiani SN; Rosenblum MD; Dell SD; Waterfield MR; Papa FR; Muzny DM; Zaitlen N; Leal SM; Gonzaga-Jauregui C; ; Boerwinkle E; Eissa NT; Gibbs RA; Lupski JR; Orange JS; Shum AK
    Nat Genet; 2015 Jun; 47(6):654-60. PubMed ID: 25894502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Obliterative bronchiolitis in lung allografts removed at retransplant for intractable airway problems.
    Akindipe O; Fernandez-Bussy S; Jantz M; Lu L; Deem A; Swafford W; Staples E; Baz M
    Respirology; 2009 May; 14(4):601-5. PubMed ID: 19383111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.